{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:34:09Z","timestamp":1759563249408,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.biomaterials.2008.08.024","type":"journal-article","created":{"date-parts":[[2008,9,18]],"date-time":"2008-09-18T12:52:56Z","timestamp":1221742376000},"page":"4808-4814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Inhibition of Taq polymerase as a method for screening heparin for oversulfated contaminants"],"prefix":"10.1016","volume":"29","author":[{"given":"Cecilia","family":"Tami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Puig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Reepmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Andre","family":"D'Avignon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucinda","family":"Buhse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Verthelyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2008.08.024_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000113702","article-title":"Neuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders","volume":"5","author":"Dudas","year":"2008","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.biomaterials.2008.08.024_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2796.2007.01878.x","article-title":"Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis","volume":"263","author":"Sjalander","year":"2008","journal-title":"J Intern Med"},{"key":"10.1016\/j.biomaterials.2008.08.024_bib3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1055\/s-2007-991536","article-title":"Heparin in tumor progression and metastatic dissemination","author":"Falanga","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.biomaterials.2008.08.024_bib4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jcp.54.4.272","article-title":"Heparin induced thrombocytopenia thrombosis (HIT\/T) syndrome: diagnosis and treatment","volume":"54","author":"Baglin","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.biomaterials.2008.08.024_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nbt0508-477","article-title":"Regulators scramble to tighten loopholes after heparin debacle","volume":"26","author":"Jia","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biomaterials.2008.08.024_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/nbt1407","article-title":"Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events","author":"Guerrini","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biomaterials.2008.08.024_bib12","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa0803200","article-title":"Contaminated heparin associated with adverse clinical events and activation of the contact system","author":"Kishimoto","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biomaterials.2008.08.024_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1021\/jm049812m","article-title":"Generation of \u201cNeoheparin\u201d from E. coli K5 capsular polysaccharide","volume":"48","author":"Lindahl","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.biomaterials.2008.08.024_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0008-6215(97)10060-X","article-title":"Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation","volume":"306","author":"Maruyama","year":"1998","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.biomaterials.2008.08.024_bib15","doi-asserted-by":"crossref","first-page":"42817","DOI":"10.1074\/jbc.M504338200","article-title":"Enzymatic redesigning of biologically active heparan sulfate","volume":"280","author":"Chen","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biomaterials.2008.08.024_bib16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1055\/s-2007-982076","article-title":"Enzymatic synthesis of glycosaminoglycan heparin","author":"Linhardt","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.biomaterials.2008.08.024_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0008-6215(96)00129-2","article-title":"Preparation and biological activity of N-sulfonated chondroitin and dermatan sulfate derivatives","volume":"290","author":"Nadkarni","year":"1996","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.biomaterials.2008.08.024_bib18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1128\/jcm.29.4.676-679.1991","article-title":"Inhibition of human immunodeficiency virus gene amplification by heparin","volume":"29","author":"Holodniy","year":"1991","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.biomaterials.2008.08.024_bib19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0167-4781(83)90096-9","article-title":"Influences of anionic polysaccharides on DNA synthesis in isolated nuclei and by DNA polymerases a: correlation of observed effects with properties of the polysaccharides","volume":"740","author":"Furukawa","year":"1983","journal-title":"Biochim Biophys Acta"},{"issue":"21","key":"10.1016\/j.biomaterials.2008.08.024_bib20","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1093\/nar\/19.21.6051","article-title":"Detection of gene expression by PCR amplification of RNA derived from frozen heparinized whole blood","volume":"19","author":"Izraeli","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biomaterials.2008.08.024_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/(SICI)1098-2825(1999)13:3<133::AID-JCLA8>3.0.CO;2-0","article-title":"Effects of heparin on polymerase chain reaction for blood white cells","volume":"13","author":"Yakota","year":"1999","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"10.1016\/j.biomaterials.2008.08.024_bib22","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2144\/03356bm03","article-title":"Heparinase treatment of RNA before quantitative real-time RT-PCR","volume":"35","author":"Johnson","year":"2003","journal-title":"Biotechniques"},{"key":"10.1016\/j.biomaterials.2008.08.024_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2141.1992.tb08216.x","article-title":"Heparin-associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycan","volume":"81","author":"Greinacher","year":"1992","journal-title":"Br J Haematol"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961208006078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961208006078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:04:32Z","timestamp":1758899072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961208006078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":18,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0142961208006078"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2008.08.024","relation":{},"ISSN":["0142-9612"],"issn-type":[{"type":"print","value":"0142-9612"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Taq polymerase as a method for screening heparin for oversulfated contaminants","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2008.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}